Epstein-Barr Virus (EBV) MicroRNAs: Involvement in cancer pathogenesis and immunopathology

International Reviews of Immunology

Volumn 32, Issue 3, 2013, Pages 271-281

  Lopes, Leandra Fiori ^a   Ruiz Miyazawa, Kenji William ^a   De Almeida, Elaine Regina Delicato ^a   Serafim, Karla Guivernau Gaudens ^a   De Almeida Gualtieri, Karina ^a,b   Costa, Ivete Conchon ^a   Felipe, Ionice ^a   Pavanelli, Wander Rogerio ^a   Watanabe, Maria Angelica Ehara ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Filadelfia University   (Brazil)

Author keywords

Cancer; EBV; MiRNA

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; MEMBRANE PROTEIN; MICRORNA; NUCLEAR PROTEIN; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELL STRESS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENOME; HUMAN; IMMUNOPATHOLOGY; MEMORY CELL; MONONUCLEOSIS; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; PROGENY; VIRUS GENE; VIRUS PARTICLE; VIRUS REPLICATION;

3' UNTRANSLATED REGIONS; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; NEOPLASMS; RNA, VIRAL;

EID: 84879123876     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.748053     Document Type: Article

References (66)

1. Klein G, Klein E, Kashuba E. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Biochem Biophys Res Commun. 2010;396(1):67-73. Epub 2010/05/25. doi: 10.1016/j.bbrc.2010.02.146. PubMed PMID: 20494113.
2. Dolcetti R, Carbone A. Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor? Infect Agents Cancer. 2010;5:22-26. Epub 2010/11/26. doi: 10.1186/1750-9378-5-22. PubMed PMID: 21092169; PubMed Central PMCID: PMC2998466.
3. Uchida E, Honma R, Igarashi A, et al. Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma. Rinsho Ketsueki. 2012;53(1):87-91. Epub 2012/03/01. PubMed PMID: 22374530.
4. Gottwein E, Cullen BR. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe. 2008;3(6):375-387. Epub 2008/06/11. doi: 10.1016/j.chom.2008.05.002. PubMed PMID: 18541214; PubMed Central PMCID: PMC3079432.
5. Cullen BR. Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev. 2011;25(18):1881-1894. Epub 2011/09/08. doi: 10.1101/gad.17352611. PubMed PMID: 21896651; PubMed Central PMCID: PMC3185961.
6. Kalla M, Hammerschmidt W. Human B cells on their route to latent infection-early but transient expression of lytic genes of Epstein-Barr virus. Eur J Cell Biol. 2012;91(1):65-69. Epub 2011/04/01. doi: 10.1016/j.ejcb.2011.01. 014. PubMed PMID: 21450364.
7. Gatto G, Rossi A, Rossi D, et al. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 2008;36(20):6608-6619. Epub 2008/10/23. doi: 10.1093/nar/gkn666. PubMed PMID: 18940871; PubMed Central PMCID: PMC2582607.
8. Bailey RE. Diagnosis and treatment of infectious mononucleosis. Am Fam Physician. 1994;49(4):879-888. Epub 1994/03/01. PubMed PMID: 8116521.
9. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998;9(3):395-404. Epub 1998/10/13. PubMed PMID: 9768759.
10. Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY. Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis. 1973;127(4):471-473. Epub 1973/04/01. PubMed PMID: 4348499.
11. Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. 2005;79(2):1296-1307. Epub 2004/12/23. doi: 10.1128/JVI.79.2.1296-1307.2005. PubMed PMID: 15613356; PubMed Central PMCID: PMC538585.
12. da Silva SR, de Oliveira DE. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies.Cancer Lett. 2011;305(2):175-185. Epub 2011/03/16. doi: 10.1016/j.canlet.2011.02.007. PubMed PMID: 21402436.
13. HummelM,Thorley-Lawson D, Kieff E. An Epstein-Barr virus DNA fragment encodes messages for the twomajor envelope glycoproteins (gp350/300 and gp220/200). J Virol. 1984;49(2):413-417. Epub 1984/02/01. PubMed PMID: 6319741; PubMed Central PMCID: PMC255481.
14. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Fields Virology. Baltimore, MD: LippincottWilliams & Wilkins; 2007. p. 2575-2627.
15. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481-492. Epub 2000/08/17. doi: 10.1056/NEJM200008173430707. PubMed PMID: 10944566.
16. Schelcher C, Valencia S, Delecluse HJ, et al. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV fromlatency. J Virol. 2005;79(21):13822-13828. Epub 2005/10/18. doi: 10.1128/JVI.79.21.13822-13828. 2005. PubMed PMID: 16227304; PubMed Central PMCID: PMC1262594.
17. Takada K, Horinouchi K, Ono Y, et al. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes. 1991;5(2):147-156. Epub 1991/04/01. PubMed PMID: 1647567.
18. Takada K, Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol. 1989;63(1):445-449. Epub 1989/01/01. PubMed PMID: 2462063; PubMed Central PMCID: PMC247705.
19. Wen W, Iwakiri D, Yamamoto K, et al. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol. 2007;81(2):1037-1042. Epub 2006/11/03. doi: 10.1128/JVI.01416-06. PubMed PMID: 17079287; PubMed Central PMCID: PMC1797481.
20. Speck SH, Chatila T, Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 1997;5(10):399-405. Epub 1997/11/14. doi: 10.1016/S0966-842X(97)01129-3. PubMed PMID: 9351176.
21. Feng WH, Westphal E, Mauser A, et al. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. J Virol. 2002;76(21):10951-10959. Epub 2002/10/09. PubMed PMID: 12368338; PubMed Central PMCID: PMC136642.
22. Al Tabaa Y, Tuaillon E,Bollore K, et al. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells. Blood. 2009;113(3):604-611. Epub 2008/10/11. doi: 10.1182/blood-2008-02-136903. PubMed PMID: 18845794.
23. Thorley-Lawson DA. EBV the prototypical human tumor virus-just how bad is it? J Allergy Clin Immunol. 2005;116(2):251-261; quiz 62. Epub 2005/08/09. doi: 10.1016/j.jaci.2005.05.038. PubMed PMID: 16083776.
24. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10(3):803-821. Epub 2004/02/12. PubMed PMID: 14871955.
25. Cai X, Schafer A, Lu S, et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006;2(3):e23. Epub 2006/03/25. doi: 10.1371/journal.ppat.0020023. PubMed PMID: 16557291; PubMed Central PMCID: PMC1409806.
26. Grundhoff A, Sullivan CS, Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA. 2006;12(5):733-750. Epub 2006/03/17. doi: 10.1261/rna.2326106. PubMed PMID: 16540699; PubMed Central PMCID: PMC1440911.
27. Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded microRNAs. Science. 2004;304(5671):734-736. Epub 2004/05/01. doi: 10.1126/science.1096781. PubMed PMID: 15118162.
28. Zhu JY, Pfuhl T,Motsch N, et al. Identification of novel Epstein-Barr virusmicroRNA genes from nasopharyngeal carcinomas. J Virol. 2009;83(7):3333-3341. Epub 2009/01/16. doi: 10.1128/JVI.01689-08. PubMed PMID: 19144710; PubMed Central PMCID: PMC2655542.
29. Gourzones C, Gelin A, Bombik I, et al. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J. 2010;7:271. Epub 2010/10/19. doi: 10.1186/1743-422X-7- 271. PubMed PMID: 20950422; PubMed Central PMCID: PMC2974674.
30. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA. 2010;107(14):6328-6333. Epub 2010/03/23. doi: 10.1073/pnas.0914843107. PubMed PMID: 20304794; PubMed Central PMCID: PMC2851954.
31. Onnis A, Navari M, Antonicelli G, et al. Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J. 2012;2:e84. Epub 2012/09/04. doi: 10.1038/bcj.2012.29. PubMed PMID: 22941339; PubMed Central PMCID: PMC3432484.
32. Lee RC, FeinbaumRL, Ambros V.The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843-854. Epub 1993/12/03. PubMed PMID: 8252621.
33. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75(5):855-862. Epub 1993/12/03. PubMed PMID: 8252622.
34. Reinhart BJ, Slack FJ, BassonM, et al.The21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901-906. Epub 2000/03/08. doi: 10.1038/35002607. PubMed PMID: 10706289.
35. Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000;408(6808):86-89. Epub 2000/11/18. doi: 10.1038/35040556. PubMed PMID: 11081512.
36. Bartel DP.MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233. Epub 2009/01/27. doi: 10.1016/j.cell.2009.01.002. PubMed PMID: 19167326.
37. Guarnieri DJ, DiLeone RJ.MicroRNAs: a new class of gene regulators. AnnMed. 2008;40(3):197-208. Epub 2008/04/03. doi: 10.1080/07853890701771823. PubMed PMID: 18382885.
38. Saito Y, Saito H. Role ofCTCF in the regulation of microRNAexpression. FrontGenet. 2012;3:186-190. Epub 2012/10/12. doi: 10.3389/fgene.2012.00186. PubMed PMID: 23056006; PubMed Central PMCID: PMC3457075.
39. Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. Gut. 2009;58(11):1546-1554. Epub 2009/10/17. doi: 10.1136/gut.2009.179531. PubMed PMID: 19834118; PubMed Central PMCID: PMC2802653.
40. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102-114. Epub 2008/01/17. doi: 10.1038/nrg2290. PubMed PMID: 18197166.
41. Huang Y, Shen XJ, Zou Q, et al. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67(1):129-139. Epub 2010/10/29. doi: 10.1007/s13105-010-0050-6. PubMed PMID: 20981514.
42. Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297. Epub 2004/01/28. PubMed PMID: 14744438.
43. Chalfie M,HorvitzHR, Sulston JE.Mutations that lead to reiterations in the cell lineages of C. elegans. Cell. 1981;24(1):59-69. Epub 1981/04/01. PubMed PMID: 7237544.
44. Ambros V. A hierarchy of regulatory genes controls a larva-to-adult developmental switch in C. elegans. Cell. 1989;57(1):49-57. Epub 1989/04/07. PubMed PMID: 2702689.
45. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell. 2004;16(6):861-865. Epub 2004/12/22. doi: 10.1016/j.molcel.2004.12.002. PubMed PMID: 15610730.
46. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123(4):631-640. Epub 2005/11/08. doi: 10.1016/j.cell.2005.10.022. PubMed PMID: 16271387.
47. Han J, Lee Y, Yeom KH, et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell. 2006;125(5):887-901. Epub 2006/06/06. doi: 10.1016/j.cell.2006.03.043. PubMed PMID: 16751099.
48. Lee Y, Jeon K, Lee JT, et al.MicroRNAmaturation: stepwise processing and subcellular localization. EMBO J. 2002;21(17):4663-4670. Epub 2002/08/29. PubMed PMID: 12198168; PubMed Central PMCID: PMC126204.
49. Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science. 2004;303(5654):95-98. Epub 2003/11/25. doi: 10.1126/science.1090599. PubMed PMID: 14631048.
50. Sivapragasam M, Rotondo F, Lloyd RV, et al. MicroRNAs in the human pituitary. Endocr Pathol. 2011;22(3):134-143. Epub 2011/06/08. doi: 10.1007/s12022-011-9167-6. PubMed PMID: 21647843.
51. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704-714. Epub 2009/09/19. doi: 10.1038/nrg2634. PubMed PMID: 19763153.
52. Barth S, Meister G, Grasser FA. EBV-encoded miRNAs. Biochim Biophys Acta. 2011;1809(11-12):631-640. Epub 2011/06/07. doi: 10.1016/j.bbagrm.2011.05.010. PubMed PMID: 21640213.
53. Skalsky RL, Cullen BR. Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PloS One. 2011;6(9):e24248. Epub 2011/09/14. doi: 10.1371/journal.pone.0024248. PubMed PMID: 21912681; PubMed Central PMCID: PMC3166303.
54. Xing L, Kieff E. Epstein-Barr virus BHRF1 micro-and stable RNAs during latency III and after induction of replication. J Virol. 2007;81(18):9967-9975. Epub 2007/07/13. doi: 10.1128/JVI.02244-06. PubMed PMID: 17626073; PubMed Central PMCID: PMC2045418.
55. Chen SJ, Chen GH, Chen YH, et al. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PloS One. 2010;5(9):e12745. Epub 2010/09/24. doi: 10.1371/journal.pone.0012745. PubMed PMID: 20862214; PubMed Central PMCID: PMC2942828.
56. Feederle R, Linnstaedt SD, Bannert H, et al. A viralmicroRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog. 2011;7(2):e1001294. Epub 2011/03/08. doi: 10.1371/journal.ppat.1001294. PubMed PMID: 21379335; PubMed Central PMCID: PMC3040666.
57. Lung RW, Tong JH, Sung YM, et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia. 2009;11(11):1174-1184. Epub 2009/11/03. PubMed PMID: 19881953; PubMed Central PMCID: PMC2767219.
58. Kim do N, Lee SK. Biogenesis of Epstein-Barr virus microRNAs. Mol Cell Biochem. 2012;365(1-2):203-210. Epub 2012/02/22. doi: 10.1007/s11010-012-1261-7. PubMed PMID: 22350759.
59. Choy EY, Siu KL, Kok KH, et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. Tohoku J Exp Med. 2008;205(11):2551-2560. Epub 2008/10/08. doi: 10.1084/jem.20072581. PubMed PMID: 18838543; PubMed Central PMCID: PMC2571930.
60. Marquitz AR, Mathur A, Nam CS, Raab-Traub N. The Epstein-Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology. 2011;412(2):392-400. Epub 2011/02/22. doi: 10.1016/j.virol.2011.01.028. PubMed PMID: 21333317.
61. Pratt ZL, Zhang J, Sugden B. The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells. J Virol. 2012;86(8):4380-4393. Epub 2012/02/10. doi: 10.1128/JVI.06966-11. PubMed PMID: 22318153; PubMed Central PMCID: PMC3318665.
62. Pratt ZL,KuzembayevaM, Sengupta S, SugdenB.ThemicroRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology. 2009;386(2):387-397. Epub 2009/02/17. doi: 10.1016/j.virol.2009.01.006. PubMed PMID: 19217135; PubMed Central PMCID: PMC2763627.
63. Chan JY, Gao W, Ho WK, et al. Overexpression of Epstein-Barr virus-encoded microRNABART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res. 2012;32(8):3201-3210. Epub 2012/07/31. PubMed PMID: 22843893.
64. Godshalk SE, Bhaduri-McIntosh S, Slack FJ. Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle. 2008;7(22):3595-3600. Epub 2008/11/13. PubMed PMID: 19001862.
65. Xia T, O'Hara A, Araujo I, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008;68(5):1436-1442. Epub 2008/03/05. doi: 10.1158/0008-5472.CAN-07-5126. PubMed PMID: 18316607; PubMed Central PMCID: PMC2855641.
66. Riley KJ, Rabinowitz GS, Yario TA, et al. EBV and humanmicroRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012;31(9):2207-2221. Epub 2012/04/05. doi: 10.1038/emboj.2012.63. PubMed PMID: 22473208; PubMed Central PMCID: PMC3343464.